01
Solid state research

XtalGazer™:

A total solution for solid state study

XtalGazer™, our integrated computational platform for solid state analysis, offers a
total solution for selection of the preferred solid form. This enables rapid drug
product development and maximizes stability, effectiveness and quality for the
lifetime of the product.

02
PROBLEM

Traditional solid state screening is difficult, time-consuming, & costly. XtalGazer™ accelerates progress while unprecedented performance and efficiency.

Guided by AI and accelerated by automated crystallization platform
Achieving quality-results under an accelerated timeline using XtalPi intelligent approach
Advantage 01
High Quality
Expertise and specialty with demonstrated experience & computational empowerment to generate definitive results by CSP with 98% coverage
Advantage 02
Speedy Delivery
25% - 50% increase in delivery speed with commitment to delivering high-quality results
Advantage 03
Flexible, Cost-effective Solutions
Tailor the proposals to meet diverse needs with flexibility to respond to changing time and budget requirements
Advantage 04
Cutting-edge Technologies
Focus on innovations, powered by proprietary prediction, automation, and MicroED platform
03
Solution

XtalGazer™ accelerates progress while lowering costs

80% increase loreum ipsum dolor sit amet
XtalGazer™ is a comprehensive solid state research platform combines computational methods with experimental techniques to identify and characterize all possible polymorphs of small molecule drugs.
03
Why Solid State

Solid State study

is mission-critical for successful drug development...

Required for IND & FDA approval

Secure the most stable forms and submit your discoveries confidently.

Stable polymorphs for clinical success

Identifying the right polymorph early on significantly increases the likelihood of clinical success.

File patents for crystal forms

Don’t leave your drug’s intellectual property exposed—XtalGazer™ ensures comprehensive coverage for every form.

04
How it Works

Delivering faster, more efficient drug discovery results with Streamlined process powered by AI & automation

XtalGazer™ combines rational design by AI with rapid execution by automation, ensuring faster, smarter, and more accurate results in solid state research.

Predict all stable
forms​
Screen polymorphs
faster
Design smarter experiments​
Make faster
decisions​
05
PERFORMANCE

Delivering faster, more efficient drug discovery results

The platform uses AI-driven accuracy to predict stable forms, enabling 24/7 automated polymorph screening. It helps design smarter experiments through computational insights, speeding up decision-making to accelerate drug development.

Traditional method
AI enhanced method
1 person
200 manual experiments designed by experts
Versus
After AI
0.4 person + AI
70 automated experiments guided by intelligent crystallization strategy
Traditional method
200
174
87%
3
AI enhanced method
70
64
92%
3
# of exp.
# of solids obtained
Hit Rate
# of discovered forms
Before AI
With AI
% of exp.
200
70
# of solids obtained
174
64
Hit Rate
92%
87%
# of discovered forms
3
3
06
XtalGazer™ Workflow

Combining AI & automation for better results

API
  • Powder sample
  • Molecular structure
Solubility & bioavailability assessment
  • XDeepSol
Virtual & experimental cocrystal & salt screening
Xtal2 experimental polymorph screening
Xtal2
AI-driven experimental polymorph screening
XtaliComplete:

Automated-aided crystallization

XtalCSP
Cloud-based crystal structure prediction platform
  • Interrogate the entire stable crystal from landscape
  • Guide and de-risk polymorph selection
Xtal structural determination
  • SCXRD
  • MicroED
Experimental crystallization process development
Morphology optimization & prediction
Toxic/clinic batch

Your next success starts here

Empower your solid state research by our total solution for solid state research
08
Facts and questions

Learn more about XtalGazer

Question goes here?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Search XtalPi

Development of small molecule selective inhibitors with XFEP
Discovery of Novel Non-covalent GPX4 Potent Hits with XFEP
Discovery of Novel Leads Targeting a Highly Flexible Allosteric Site with XMolGen and XFEP